Loading organizations...
Baze has raised $6.0M across 1 funding round.
Key people at Baze.
Baze has raised $6.0M in total across 1 funding round.
Baze is a personalized nutrition company based in Berlin, Germany, and Boston, Massachusetts, that provides at-home blood testing kits and customized daily vitamin subscriptions based on individual biomarker analysis. The direct-to-consumer platform charges a $79 monthly subscription fee for personalized supplement packs designed to address specific micronutrient deficiencies and eliminate up to 73 percent of nutrient gaps within three months. Prior to its strategic acquisition, the health technology firm secured FDA clearance for its proprietary blood collection device and achieved a historical 40 percent month-over-month subscriber growth rate. The enterprise raised approximately $6 million in venture funding from prominent institutional investors including Ringier Digital Ventures before being acquired by Schwabe Group subsidiary Nature's Way in December 2020. Operating within the broader health and wellness sector, Baze was originally founded in 2014 by Philipp Schulte and Isam Haddad.
Baze has raised $6.0M in total across 1 funding round.
Baze's investors include Nature's Way.
Baze (baze-app) is a Milan-based startup that operates an AI-powered platform connecting families with verified domestic workers, such as babysitters and household staff. It serves families seeking reliable hires and workers looking for formal employment, solving inefficiencies in the domestic job market—like high agency costs, poor matching, and illegal work—through smart algorithms, digital contracts, and payment tools that enable quick transitions from match to regular work.[1][8]
The company has shown early growth with €650K in funding from investors like Fondazione CR Firenze and Nana Bianca, positive reviews highlighting its problem-solving in a large, undigitized market, and a team iterating via lean methods (learn-build-measure).[1][8] Note: Other entities named "Baze" exist (e.g., a former personalized nutrition company acquired in 2021[2][3][6] and a chemical firm sold in 2021[4]), but context points to the domestic employment platform as the active startup.[1][8]
Baze was founded in Italy around 2022–2023 by Matteo Pervan (Milan), Davide (Bologna), Marco Fabbri (noted for software expertise and prior ventures), and two others in Padova.[1] The idea emerged from identifying a massive, inefficient domestic employment market plagued by illegal work and outdated agencies; the team focused on digitizing matching, verification, and management with AI.[1][8]
Early traction came from investor endorsements praising the founders' iteration speed and market insight, leading to a €650K funding round to scale as the "smart, reliable service" for domestic workers.[1][8]
Baze rides the future of work and gig economy digitization trend, targeting domestic services—a €multi-billion European market slow to adopt tech amid labor shortages and regulatory pushes against informal work.[1][8] Timing aligns with post-pandemic demand for flexible household staffing and AI tools in HR, amplified by Europe's aging population and urban family needs.
Market forces like rising illegal employment crackdowns and AI advancements favor Baze, positioning it to influence the ecosystem by formalizing gigs, reducing agency monopolies, and creating data-driven benchmarks for family services platforms.[1][8]
Baze is poised to dominate Italy's domestic staffing market, expanding AI features like predictive matching or integrated payroll while entering adjacent EU countries with similar inefficiencies. Trends like AI in HR and regulatory emphasis on formal work will accelerate growth, potentially attracting larger VC rounds or acquisitions by job platforms.
As domestic work digitizes, Baze could redefine family-worker relationships, scaling from local traction to a pan-European standard—echoing its mission to eliminate supply-demand gaps.[1][8]
Key people at Baze.
Baze has raised $6.0M across 1 funding round. Most recently, it raised $6.0M Series A in August 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 30, 2019 | $6M Series A | Nature's WAY | — | Announced |
